FDA Inspection
Louise Taber, MDLouise Taber, MD – FDA Inspection, Jul 18, 2014
Record Details
This FDA Inspection record concerns Louise Taber, MD, with an inspection on July 18, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Louise Taber, MD
- Inspection Date
- July 18, 2014
- Product Type
- Drugs
View Company Profile
ID · 9c1b4936-be59-4932-9b01-2f136eedb92f
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 888259
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Louise Taber, MD
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 26, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 20, 2016 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Louise Taber, MD
- FDA Inspection 1251100 - 2024-09-26
- FDA Inspection 971681 - 2016-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.